Feasibility Study of Personalized Peptide Vaccination for Advanced Non-Small Cell Lung Cancer Patients Who Failed Two or More Treatment Regimens

International Journal of Oncology - Greece
doi 10.3892/ijo.2014.2699
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

P1.12-03 a Prospective Study of Apatinib in Advanced Small Cell Lung Cancer Patients Failed From Two or More Lines of Chemotherapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Feasibility Study of Personalized Peptide Vaccination for Metastatic Recurrent Triple-Negative Breast Cancer Patients

Breast Cancer Research
Cancer ResearchOncology
2014English

Treatment Results Including More Than Third-Line Chemotherapy for Patients With Advanced Non-Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2010English

Feasibility of Stereotactic Body Radiotherapy for Locally-Advanced Non-Small Cell Lung Cancer

Clinical and Translational Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2017English

Afatinib Treatment in Advanced Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2011English

Advanced Non-Small Cell Lung Cancer in Elderly Patients

Breathe
PulmonaryRespiratory Medicine
2012English

Are VEGFR-TKIs Effective or Safe for Patients With Advanced Non-Small Cell Lung Cancer?

Oncotarget
Oncology
2015English

Targeted Therapy for the Treatment of Advanced Non-Small Cell Lung Cancer

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Personalized Peptide Vaccination for Cervical Cancer Patients Who Have Received Prior Platinum-Based Chemotherapy

Cancer Science
Cancer ResearchMedicineOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy